124 related articles for article (PubMed ID: 26970678)
1. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes.
Sole CV; Calvo FA; Alvarez E; Cambeiro M; Cuervo M; San Julian M; Sole S; Martinez-Monge R; Sierrasesumaga L
Radiother Oncol; 2016 Apr; 119(1):30-4. PubMed ID: 26970678
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative Electron-Beam Radiation Therapy for Pediatric Ewing Sarcomas and Rhabdomyosarcomas: Long-Term Outcomes.
Sole CV; Calvo FA; Polo A; Cambeiro M; Gonzalez C; Desco M; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1069-1076. PubMed ID: 26194682
[TBL] [Abstract][Full Text] [Related]
3. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for local control of osteosarcoma.
DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
[TBL] [Abstract][Full Text] [Related]
6. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
7. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
8. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
10. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
[TBL] [Abstract][Full Text] [Related]
11. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
[TBL] [Abstract][Full Text] [Related]
12. Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.
Meazza C; Luksch R; Daolio P; Podda M; Luzzati A; Gronchi A; Parafioriti A; Gandola L; Collini P; Ferrari A; Casanova M; Terenziani M; Spreafico F; Polastri D; Biassoni V; Schiavello E; Pecori E; Massimino M
Med Oncol; 2014 Apr; 31(4):875. PubMed ID: 24557586
[TBL] [Abstract][Full Text] [Related]
13. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma.
Aung L; Gorlick R; Healey JH; Shi W; Thaler HT; Shorter NA; Huvos AG; Meyers PA
J Clin Oncol; 2003 Jan; 21(2):342-8. PubMed ID: 12525528
[TBL] [Abstract][Full Text] [Related]
14. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.
Machak GN; Tkachev SI; Solovyev YN; Sinyukov PA; Ivanov SM; Kochergina NV; Ryjkov AD; Tepliakov VV; Bokhian BY; Glebovskaya VV
Mayo Clin Proc; 2003 Feb; 78(2):147-55. PubMed ID: 12583525
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
[TBL] [Abstract][Full Text] [Related]
17. Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study.
Larsen F; Terlizzi M; Linacre V; Sargos P; Suarez F; Kirova Y; Van Houtte P; Lerouge D; Zilli T; Sole CV
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1175-1181. PubMed ID: 30578911
[TBL] [Abstract][Full Text] [Related]
18. Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck.
Mücke T; Mitchell DA; Tannapfel A; Wolff KD; Loeffelbein DJ; Kanatas A
J Cancer Res Clin Oncol; 2014 Jan; 140(1):127-31. PubMed ID: 24276589
[TBL] [Abstract][Full Text] [Related]
19. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
Ciernik IF; Niemierko A; Harmon DC; Kobayashi W; Chen YL; Yock TI; Ebb DH; Choy E; Raskin KA; Liebsch N; Hornicek FJ; Delaney TF
Cancer; 2011 Oct; 117(19):4522-30. PubMed ID: 21448934
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
